Cargando…
Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies
The blockade of immune regulatory checkpoints is emerging as a powerful anticancer strategy. We recently reported long-term results from the first-in-human clinical trial of anti-PD1 antibody-based immunotherapy, demonstrating durable tumor control off-therapy in subjects affected by colorectal and...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654592/ https://www.ncbi.nlm.nih.gov/pubmed/23734322 http://dx.doi.org/10.4161/onci.23661 |